Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2539 | 2143 | 27.2 | 49% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 810 | 11347 | HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//HISTAMINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SUCRALFATE | Author keyword | 6 | 14% | 2% | 41 |
| 2 | PEPTIC ULCER THERAPY | Author keyword | 3 | 57% | 0% | 4 |
| 3 | DE NOL | Author keyword | 3 | 60% | 0% | 3 |
| 4 | HISTAMINE H 2 ANTAGONIST | Author keyword | 3 | 60% | 0% | 3 |
| 5 | T 593 | Author keyword | 3 | 60% | 0% | 3 |
| 6 | INTRAGASTRIC ACIDITY | Author keyword | 3 | 25% | 0% | 9 |
| 7 | ACTIVE DUODENAL ULCER | Author keyword | 2 | 67% | 0% | 2 |
| 8 | ALUMINUM CONTAINING ANTACIDS | Author keyword | 2 | 67% | 0% | 2 |
| 9 | BEDTIME DOSE | Author keyword | 2 | 67% | 0% | 2 |
| 10 | CAS 120958 90 9 | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SUCRALFATE | 6 | 14% | 2% | 41 | Search SUCRALFATE | Search SUCRALFATE |
| 2 | PEPTIC ULCER THERAPY | 3 | 57% | 0% | 4 | Search PEPTIC+ULCER+THERAPY | Search PEPTIC+ULCER+THERAPY |
| 3 | DE NOL | 3 | 60% | 0% | 3 | Search DE+NOL | Search DE+NOL |
| 4 | HISTAMINE H 2 ANTAGONIST | 3 | 60% | 0% | 3 | Search HISTAMINE+H+2+ANTAGONIST | Search HISTAMINE+H+2+ANTAGONIST |
| 5 | T 593 | 3 | 60% | 0% | 3 | Search T+593 | Search T+593 |
| 6 | INTRAGASTRIC ACIDITY | 3 | 25% | 0% | 9 | Search INTRAGASTRIC+ACIDITY | Search INTRAGASTRIC+ACIDITY |
| 7 | ACTIVE DUODENAL ULCER | 2 | 67% | 0% | 2 | Search ACTIVE+DUODENAL+ULCER | Search ACTIVE+DUODENAL+ULCER |
| 8 | ALUMINUM CONTAINING ANTACIDS | 2 | 67% | 0% | 2 | Search ALUMINUM+CONTAINING+ANTACIDS | Search ALUMINUM+CONTAINING+ANTACIDS |
| 9 | BEDTIME DOSE | 2 | 67% | 0% | 2 | Search BEDTIME+DOSE | Search BEDTIME+DOSE |
| 10 | CAS 120958 90 9 | 2 | 67% | 0% | 2 | Search CAS+120958+90+9 | Search CAS+120958+90+9 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LOW DOSE ANTACIDS | 12 | 86% | 0% | 6 |
| 2 | BENIGN GASTRIC ULCER | 8 | 50% | 1% | 11 |
| 3 | RANITIDINE 300 MG | 7 | 67% | 0% | 6 |
| 4 | ACTIVATED ALUMINUM COMPLEX | 6 | 100% | 0% | 4 |
| 5 | H2 ANTAGONISTS | 6 | 100% | 0% | 4 |
| 6 | TRIPOTASSIUM DICITRATO BISMUTHATE | 5 | 21% | 1% | 22 |
| 7 | CIMETIDINE TREATMENT | 5 | 29% | 1% | 15 |
| 8 | 300 MG | 4 | 47% | 0% | 7 |
| 9 | DE NOL | 4 | 32% | 1% | 11 |
| 10 | ANTRAL PH | 4 | 75% | 0% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| SUCRALFATE | 1991 | 127 | 85 | 67% |
| DRUG-THERAPY - HISTAMINE2-RECEPTOR ANTAGONISTS - STANDARD THERAPY FOR ACID-PEPTIC DISEASES .2. | 1990 | 105 | 68 | 35% |
| Placebo effect in the treatment of duodenal ulcer | 1999 | 51 | 57 | 60% |
| COLLOIDAL BISMUTH SUBCITRATE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC USE IN PEPTIC-ULCER DISEASE | 1988 | 81 | 76 | 72% |
| Smoking and peptic ulcer in the Helicobacter pylori era | 2000 | 34 | 121 | 23% |
| HISTAMINE H-2-RECEPTOR ANTAGONISTS IN PEPTIC-ULCER DISEASE - EFFICACY IN HEALING PEPTIC-ULCERS | 1992 | 27 | 76 | 55% |
| OVERVIEW OF MEDICAL THERAPY OF PEPTIC-ULCER DISEASE | 1990 | 39 | 72 | 54% |
| THE RISKS AND BENEFITS OF AN RX-TO-OTC SWITCH - THE CASE OF OVER-THE-COUNTER H2-BLOCKERS | 1990 | 32 | 75 | 63% |
| SUCRALFATE - THE BANGKOK REVIEW | 1994 | 15 | 22 | 64% |
| RANITIDINE - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PEPTIC-ULCER DISEASE AND OTHER ALLIED DISEASES | 1989 | 110 | 342 | 31% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ECON MATH STAT SCI | 1 | 50% | 0.1% | 2 |
| 2 | DIAGNOST CANC GASTR | 1 | 50% | 0.0% | 1 |
| 3 | DIRECTORATE CHEM PETROCHEM IND | 1 | 50% | 0.0% | 1 |
| 4 | F NO PROGRAM | 1 | 50% | 0.0% | 1 |
| 5 | MED 3 CLIN | 1 | 50% | 0.0% | 1 |
| 6 | SURG HOSP 2 | 1 | 50% | 0.0% | 1 |
| 7 | SWALLOWING OESOPHAGEAL DISORDERS | 1 | 50% | 0.0% | 1 |
| 8 | CASTEL S PIETRO TERME HOSP | 1 | 29% | 0.1% | 2 |
| 9 | CHEM PHARMACOL PHYTOCHEM | 0 | 33% | 0.0% | 1 |
| 10 | AUSL IMOLA | 0 | 17% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000184851 | HEIDELBERG CAPSULE//ROXATIDINE ACETATE//SECT PEDIAT CLIN PHARMACOL TOXICOL |
| 2 | 0.0000164319 | HVIDOVRE HOSP ENDOCRINOL//E170//MALE SEXUAL HLTH |
| 3 | 0.0000161894 | ENPROSTIL//E2 PROSTAGLANDINS//NOCLOPROST |
| 4 | 0.0000151533 | ANTACID ACTIVITY//ARTIFICIAL STOMACH DUODENUM//ARTIFICIAL STOMACH DUODENUM MODEL |
| 5 | 0.0000134663 | CIRCADIAN RHYTHM OF HORMONES//HOSP DELTA//HEMORRHAGIC GASTRITIS |
| 6 | 0.0000126088 | OMEPRAZOLE//LANSOPRAZOLE//PANTOPRAZOLE |
| 7 | 0.0000115024 | IDIOPATHIC PEPTIC ULCER//DUODENAL PEPTIC ULCER//ATTITUDE TO THE DISEASE |
| 8 | 0.0000108381 | LEAD FREE BRONZE//COMPOUND SEPARATION METHOD//BIPP |
| 9 | 0.0000098068 | CAS 76963 41 2//MIFENTIDINE//HISTAMINE H 2 RECEPTORS |
| 10 | 0.0000092637 | PERFORATED PEPTIC ULCER//PEPTIC ULCER PERFORATION//PERFORATED DUODENAL ULCER |